Infliximab-induced eczematid-like purpura of Doucas and Kapetenakis.
Wang
Linda C
LC
Medenica
Maria M
MM
Shea
Christopher R
CR
Busbey
Shail
S
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy; D003879:Dermatologic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D000069285:Infliximab; D011693:Purpura / Q000139:chemically induced* / Q000473:pathology
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab